Merdad Parsey - Sep 10, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Medical Officer
Signature: /s/ Edward S. Son by Power of Attorney for Merdad Parsey
Stock symbol: GILD
Transactions as of: Sep 10, 2022
Transactions value $: -$31,400
Form type: 4
Date filed: 9/12/2022, 04:05 PM
Previous filing: Jun 13, 2022
Next filing: Nov 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+1.04K	+2.46%		43.2K	Sep 10, 2022	Direct	F1
transaction	GILD	Common Stock	Tax liability	-$31.4K	-481	-1.11%	$65.28	42.7K	Sep 10, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-1.04K	-2.03%		50.2K	Sep 10, 2022	Common Stock	1.04K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.